NYSE: XPRO

Expro Ltd

CIK 0002126198 · SIC 1389 · Oil & Gas Field Services, NEC

No XBRL size data yet — common for recent IPOs and new registrants (SEC companyfacts lag), foreign filers reporting in non-USD, or non-standard filers.

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.

10-Q Filed Jul 28, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 28, 2026 · Period ending Jul 28, 2026

Summary not yet generated.

Partner

Trade XPRO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B3 Filed Apr 21, 2026

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(In thousands, except share data)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Total revenue 393,182 422,740 760,755 813,612
Operating costs and expenses:
Cost of revenue, excluding depreciation and amortization expense (311,158) (319,981) (608,772) (625,473)
General and administrative expense, excluding depreciation and amortization expense (19,655) (14,499) (37,549) (36,313)
Depreciation and amortization expense (45,792) (46,716) (91,187) (92,137)
Merger and integration expense (3,634) (2,267) (3,922) (4,007)
Severance and other expense (2,572) (6,711) (5,798) (12,793)
Total operating cost and expenses (382,811) (390,174) (747,228) (770,723)
Operating income 10,371 32,566 13,527 42,889
Other (expense) income, net (242) 280 105 1,934
Interest and finance expense, net (2,712) (4,279) (4,263) (7,730)
Income before taxes and equity in income of joint ventures 7,417 28,567 9,369 37,093
Equity in income of joint ventures 2,763 3,395 5,994 7,101
Income before income taxes 10,180 31,962 15,363 44,194
Income tax expense (8,152) (13,959) (14,369) (12,243)
Net income 2,028 18,003 994 31,951
Earnings per common share:
Basic 0.02 0.16 0.01 0.28
Diluted 0.02 0.16 0.01 0.27
Weighted average common shares outstanding:
Basic 113,098,653 115,444,915 113,360,028 115,829,219
Diluted 114,446,970 115,508,918 115,049,304 116,216,865

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands)

Description June 30, 2026 December 31, 2025
Assets:
Current assets
Cash and cash equivalents 199,531 196,093
Restricted cash 35 1,380
Accounts receivable, net 477,237 477,026
Inventories 170,586 167,895
Income tax receivables 38,181 31,654
Other current assets 98,202 86,287
Total current assets 983,772 960,335
Property, plant and equipment, net 514,613 523,157
Investments in joint ventures 79,779 78,706
Intangible assets, net 227,974 251,329
Goodwill 348,558 348,558
Operating lease right-of-use assets 77,796 72,777
Non-current accounts receivable, net 7,432 7,432
Post-retirement benefits 3,396 -
Other non-current assets 17,018 17,141
Total assets 2,260,338 2,259,435
Liabilities and stockholders’ equity:
Current liabilities
Accounts payable and accrued liabilities 304,808 268,588
Income tax liabilities 54,131 51,111
Finance lease liabilities 1,540 2,359
Operating lease liabilities 20,317 18,225
Other current liabilities 99,835 103,379
Total current liabilities 480,631 443,662
Long-term borrowings 79,065 79,065
Deferred tax liabilities, net 15,154 19,513
Post-retirement benefits - 314
Non-current finance lease liabilities 12,124 12,762
Non-current operating lease liabilities 58,259 56,103
Uncertain tax positions 73,355 77,890
Other non-current liabilities 36,198 36,003
Total liabilities 754,786 725,312
Commitments and contingencies (Note 17)
Stockholders’ equity:
Common stock, €0.06 nominal value, 200,000 shares authorized, 122,590 and 122,384 shares issued 8,570 8,559
Treasury stock (at cost) 10,379 and 8,823 shares (154,153) (127,137)
Additional paid-in capital 2,107,739 2,110,177
Accumulated other comprehensive income 17,931 18,053
Accumulated deficit (474,535) (475,529)
Total stockholders’ equity 1,505,552 1,534,123
Total liabilities and stockholders’ equity 2,260,338 2,259,435

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net income 994 31,951
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense 91,187 92,137
Equity in income of joint ventures (5,994) (7,101)
Stock-based compensation expense 15,554 14,282
Elimination of unrealized loss on sales to joint ventures 260 -
Deferred taxes (4,360) (16,049)
Unrealized foreign exchange loss (gain) 3,127 (6,047)
Changes in assets and liabilities:
Accounts receivable, net (1,995) 15,118
Inventories (2,691) (9,020)
Other assets (11,921) (11,557)
Accounts payable and accrued liabilities 34,852 (17,289)
Other liabilities (4,614) 12,931
Income taxes, net (8,042) (6,599)
Dividends received from joint ventures 4,662 498
Other (4,273) (3,333)
Net cash provided by operating activities 106,746 89,922
Cash flows from investing activities:
Capital expenditures (56,948) (54,316)
Proceeds from disposal of assets - 5,000
Net cash used in investing activities (56,948) (49,316)
Cash flows from financing activities:
Release of (cash pledged for) collateral deposits, net 113 (415)
Proceeds from borrowings 1,794 -
Repurchase of common stock (39,998) (15,033)
Payment of withholding taxes on stock-based compensation plans (5,003) (2,588)
Repayment of financed insurance premium (526) (4,955)
Repayments of finance leases (1,525) (887)
Net cash used in financing activities (45,145) (23,878)
Effect of exchange rate changes on cash and cash equivalents (2,560) 6,095
Net increase to cash and cash equivalents and restricted cash 2,093 22,823
Cash and cash equivalents and restricted cash at beginning of period 197,473 184,663
Cash and cash equivalents and restricted cash at end of period 199,566 207,486

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗